Now showing items 1-1 of 1

    • Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice. 

      Cordoba-Chacon, J.; Majumdar, N.; List, EO; Diaz-Ruiz, A.; Frank, SJ; Manzano, A.; Bartrons, R.; Puchowicz, M.; Kopchick, JJ; Kineman, RD (American Diabetes Association, 2015-09)
      Patients with nonalcoholic fatty liver disease (NAFLD) are reported to have low growth hormone (GH) production and/or hepatic GH resistance. GH replacement can resolve the fatty liver condition in diet-induced obese rodents ...